Additional file 9 of Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma

肿瘤免疫治疗预后预测

Additional file 9. Supplementary Table 8. Univariate cox analysis on clinical features

NIAID Data Ecosystem20

Additional file 7 of Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma

肺腺癌免疫分子分型

预后与治疗反应预测

Additional file 7. Supplementary Table 6: Results of univariate cox regression analysis on survival related LICMGs

NIAID Data Ecosystem10

DataSheet8_Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts.PDF

膀胱癌分子分型

预后与治疗反应预测

Bladder cancer (BLCA) is a heterogeneous disease, and there are many classical molecular subtypes that reflect tumor immune microenvironment (TME) heterogeneity but their clinical utility is limited a

NIAID Data Ecosystem00

Additional file 13 of Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma

资源简介：

Additional file 13 of Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma

资源简介：

相关数据集